Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Breast 2Gynecologic 1Genitourinary 1

Conditions

Thrombocytopenia 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Blast Crisis 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia 3Fanconi Anemia, Complementation Group D1 3Breast Neoplasms 3Anemia, Refractory, with Excess of Blasts 3Prostatic Neoplasms 2Primary Myelofibrosis 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Promyelocytic, Acute 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Intraocular Lymphoma 2Congenital Abnormalities 2Anemia 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Triple Negative Breast Neoplasms 1Thrombocytosis 1

Interventions

olaparib 9Carboplatin 3talazoparib 1pembrolizumab 1liposomal doxorubicin 1iniparib 1Trabectedin 1Surveys and Questionnaires 1Secretin 1Paclitaxel 1Genotype 1Genetic Counseling 1Demography 1Data Collection 1Counseling 1Cognitive Behavioral Therapy 1Biopsy, Fine-Needle 1ABT-767 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Fanconi Anemia, Complementation Group D1 × Carboplatin × Classical hematology × Clear all
NCT04038502 2025-08-20

COBRA

VA Office of Research and Development

Phase 2 Recruiting
100 enrolled
Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group N, Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT05485766 2025-03-20

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Okayama University

Phase 2 Recruiting
23 enrolled
BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02418624 2019-01-16

REVIVAL

The Netherlands Cancer Institute

Phase 1 Completed
25 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡